相关实验视频

Updated: Jul 4, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

确定肺癌潜在的监管机制和治疗目标

Anjali Priya^1,2, Mohammed Dashti³, Thangavel Alphonse Thanaraj³

¹Department of Environmental Studies, University of Delhi, New Delhi, India.

Journal of biomolecular structure & dynamics

|February 6, 2024

概括

这项研究确定ASPM和MKI67是肺癌网络中的关键基因,为早期检测和向治疗提供了潜力. 甲托雷克萨特作为一种有希望的治疗方法,得到了分子对接和模拟研究的支持.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
分子生物学分子生物学

背景情况:

肺癌是全球主要的健康挑战,生存率很低,需要改进早期检测和治疗策略.
识别关键的分子标记物和理解它们的相互作用对于开发有效的治疗干预措施至关重要.

研究的目的:

为了确定关键的基因和参与肺癌进展的途径.
探索肺癌治疗的潜在治疗点和候选药物.

主要方法:

使用BioXpress数据库进行基因识别,使用DAVID进行丰富分析,使用网络理论进行相互作用分析.
采用GEPIA和KM Plotter进行基因表达分析,以及分子对接/动力学模拟 (瑞士码头,AMBER 16) 进行药物验证.
预测微RNA和转录因子相互作用以阐明调节机制.

主要成果:

确定ASPM和MKI67作为肺癌网络中的关键调节基因.
通过基因表达模式分析,ASPM和MKI67显示出显著的临床相关性.
甲索被预测为一种潜在的治疗剂,分子对接和动力学模拟证实了有利的结合相互作用.

结论:

ASPM和MKI67是肺癌的重要调节剂,具有作为生物标志物和治疗点的潜力.
这项研究强调了甲状腺素作为肺癌的有希望的候选药物,得到了计算证据的支持.
结果为开发个性化治疗策略和进一步实验验证提供了基础.

关键词:

肺癌是一种肺癌.关键监管机构关键监管机构网络理论网络理论蛋白质与蛋白质相互作用网络 (PPI)治疗生物标志物.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...